1260339

Eli Lilly & Company — FEI 1819470

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 27, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Indianapolis, IN (United States)

Additional Details

Sponsor, Contract Research Organization